Access Fractyl Stock and Financial Details

Q: Can you buy Fractyl stock?

You can no longer buy Fractylstock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

Enterprise Value

Access valuation and stock price for companies like Fractyl before its IPO.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Fractyl stock FAQs

Can you buy Fractyl stock?

You can no longer buy Fractyl stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy Fractyl stock?

To invest in a private company like Fractyl through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Fractyl stock?

You can no longer sell stock of Fractyl on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell Fractyl stock?

If you hold private company shares of Fractyl - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Fractyl stock on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is Fractyl a public company?

No, Fractyl is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Fractyl’s stock ticker symbol?

The ticker symbol of Fractyl is GUTS.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Team

Management Team

Jay Caplan

President, Board Member & Co-Founder

Harith Rajagopalan Ph.D

Co-Founder, Chief Executive Officer and Board Member

Diane Marcou

Chief Financial Officer

Lisa Davidson

Chief Financial Officer

David Maggs

Chief Medical Officer

Board Members

Ajay Royan

Mithril Capital Management

Hemant Taneja

General Catalyst

William Bradley

Brian Dovey

Domain Associates

Christopher Gabrieli MD

Bessemer Venture Partners

Jay Caplan

Stanley Lapidus

Allan Will

Harith Rajagopalan Ph.D

John Amatruda

Fierce Biotech 01/29/2024

Fractyl Sets Out $99M IPO Ambitions After Busy Week of Biotechs Going Public

Fractyl Health, a biotechnology startup that focuses on preventing and curing metabolic diseases, announced in December 2023 that an initial public offering (IPO) may happen for the company. The company is sticking to that plan by selling 7.3 million shares for $14 to $16 each to add $99 million in capital. Fractyl Health has tested its Rejuva gene therapy candidate, which is a treatment that may compete with semaglutide drug Wegovy from pharmaceutical researcher Novo Nordisk.

Seeking Alpha 12/17/2023

Fractyl Health Aims For $100 Million IPO Raise

Fractyl Health, which is a startup that designs medical therapies for metabolic health, filed with the SEC to raise $100 million through an initial public offering (IPO). Specifically, the Lexington, Massachusetts-based company is working to treat Type 2 Diabetes as well as obesity in patients, and Fractyl Health will use the IPO capital to complete its Revitalize-1 research, fund the Remain-1 study and development of Rejuva gene therapy candidates, and prepare for commercialization of its therapies.

FinSMEs 11/30/2017

Fractyl Completes $44M Series D Financing |FinSMEs

Fractyl Laboratories Inc., a Lexington, Mass.-based developer of minimally invasive procedural therapy that can reverse metabolic diseases, completed a $44m Series D financing. The round was led by an undisclosed new investor, joined by new investors GV, True Ventures, and the IDO Fund and returning investors General Catalyst, Bessemer Venture Partners, Domain Associates, Mithril Capital …

Fractyl Stock

Register To Buy and Sell Private Company Shares